dactinomycin has been researched along with vorinostat in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodská, B; Holoubek, A | 1 |
| Almacellas, E; Ambrosio, S; Cortes, CL; Ferreres, JC; Hernández-Losa, J; Kozma, SC; Tauler, A; Thomas, G; Veiga, SR | 1 |
1 review(s) available for dactinomycin and vorinostat
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for dactinomycin and vorinostat
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Generation of reactive oxygen species during apoptosis induced by DNA-damaging agents and/or histone deacetylase inhibitors.
Topics: Antineoplastic Agents; Apoptosis; Azacitidine; Butyrates; Caspase 3; Cell Line, Tumor; Cytostatic Agents; Dactinomycin; Decitabine; DNA Damage; Drug Synergism; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Poly(ADP-ribose) Polymerases; Reactive Oxygen Species; Vorinostat | 2011 |
Effect of low doses of actinomycin D on neuroblastoma cell lines.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Dactinomycin; Dose-Response Relationship, Drug; Drug Synergism; Female; Hydroxamic Acids; Imidazoles; Mice; Neuroblastoma; Piperazines; Proto-Oncogene Proteins c-myc; Time Factors; Tumor Suppressor Protein p53; Vorinostat | 2016 |